Actively Recruiting

Early Phase 1
Age: 18Years - 65Years
All Genders
NCT07091318

CBTi for the Treatment of Insomnia in Type 1 Diabetes

Led by University of Illinois at Chicago · Updated on 2026-01-22

15

Participants Needed

1

Research Sites

82 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this study is to learn if treating insomnia with a therapy intervention in people with type 1 diabetes will help to better control sugar levels, sleep, and quality of life. The questions this study aims to answer include: Will this intervention help the insomnia symptoms? Will obtaining better sleep aid in the control of diabetes through measures like sugar levels? Will the intervention help with quality of life factors like mood and fatigue? Researchers will compare participants receiving the therapy intervention for sleep with those in the "healthy living" intervention to see if the outcomes are different based on the treatment. Participants in the therapy intervention group will: * meet virtually with a therapist for 8 sessions via Zoom. Once a week for the first 4 weeks and then every other week for the last 4 sessions. Participants in the healthy living group will: * receive weekly health education emails * receive brief weekly calls from a coach to answer any questions Participants, regardless of intervention, over the 12 week study period will: * monitor their sleep for 2 weeks through a sleep-monitoring watch * share their continuous glucose monitoring data throughout the study * answer questionnaires prior to the intervention, halfway through the intervention and then after the intervention * attend 3 in person office visits

CONDITIONS

Official Title

CBTi for the Treatment of Insomnia in Type 1 Diabetes

Who Can Participate

Age: 18Years - 65Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Between 18 to 65 years old
  • Diagnosed with Type 1 Diabetes for at least one year
  • Use a continuous glucose monitor
  • Have poor sleep quality
  • Able to attend 3 office visits
Not Eligible

You will not qualify if you...

  • Currently pregnant or planning pregnancy or breastfeeding
  • Employed with a rotating or night shift
  • At high risk for obstructive sleep apnea
  • Non-English speaking (unable to participate in therapy or questionnaires)
  • Taking medications for sleep
  • Moderately severe to severe depression
  • Significant medical history including heart failure, cirrhosis, COPD, diseases requiring oxygen, active cancer treatment, psychiatric problems, history of stroke with neurological deficits, cognitive impairment, kidney failure requiring dialysis, illicit drug use, or use of ADHD stimulant medications

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Illinois Chicago

Chicago, Illinois, United States, 60612

Actively Recruiting

Loading map...

Research Team

J

Jennifer Duffecy, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here